Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non Operating Income (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Non Operating Income over the past 16 years, most recently at $171000.0 for Q2 2025.

  • Quarterly results put Non Operating Income at $171000.0 for Q2 2025, up 115.52% from a year ago — trailing twelve months through May 2025 was -$3000.0 (up 99.9% YoY), and the annual figure for FY2025 was -$3000.0, up 99.9%.
  • Non Operating Income for Q2 2025 was $171000.0 at Lifecore Biomedical, Inc. \De\, down from $333000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for LFCR hit a ceiling of $736000.0 in Q2 2022 and a floor of -$1.1 million in Q2 2024.
  • Median Non Operating Income over the past 5 years was -$109500.0 (2021), compared with a mean of -$142111.1.
  • Biggest five-year swings in Non Operating Income: skyrocketed 1602.04% in 2022 and later tumbled 882.69% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Non Operating Income stood at $330000.0 in 2021, then plummeted by 171.82% to -$237000.0 in 2022, then crashed by 308.02% to -$967000.0 in 2023, then surged by 68.56% to -$304000.0 in 2024, then skyrocketed by 156.25% to $171000.0 in 2025.
  • The last three reported values for Non Operating Income were $171000.0 (Q2 2025), $333000.0 (Q1 2025), and -$304000.0 (Q4 2024) per Business Quant data.